Assessment of the role of various factors in the development of arterial hypertension in workers of chemical enterprises by applying machine learning
https://doi.org/10.25789/YMJ.2025.90.16
Abstract
The article examines the contribution of production-related and non-production risk factors to the development of arterial hypertension in workers in ethylbenzene-styrene (EBS) and ethylene-propylene (EP) chemical industries, which differ in the degree of automation of the technological process, using the gradient boosting method.
The factors that have the greatest impact on the prognosis of arterial hypertension development have been identified. For EBS production workers, the major factors influencing AH risk were work experience, age, and smoking. For the Ethylene-Propylene (EP) operators, the key factors were work experience, smoking, and LDL levels.
Taking into account the identified risk factors, targeted measures have been developed to minimize them.
About the Authors
N. A. MuldashevaRussian Federation
I. I. Zaydullin
Russian Federation
D. O. Karimov
Russian Federation
L. K. Karimova
Russian Federation
I. V. Shapoval
Russian Federation
Z. F. Gimaeva
Russian Federation
References
1. Adhikary D, Barman S, Ranjan R, Stone H. A Systematic Review of Major Cardiovascular Risk Factors: A Growing Global Health Concern. Cureus. 2022 Oct 10;14(10):e30119. doi: 10.7759/cureus.30119.
2. Assadi SN. Cardiovascular disorders and exposure to chemical pollutants. J Prev Med Hyg. 2024 Mar 31;65(1):E59-E64. doi: 10.15167/2421-4248/jpmh2024.65.1.3126.
3. Gallucci G, Tartarone A, Lerose R, Lalinga AV, Capobianco AM. Cardiovascular risk of smoking and benefits of smoking cessation. J Thorac Dis. 2020 Jul;12(7):3866-3876. doi: 10.21037/jtd.2020.02.47.
4. Global Cardiovascular Risk Consortium, Magnussen C, Ojeda FM, et al. Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality. N Engl J Med. 2023;389(14):1273-1285. doi:10.1056/NEJMoa2206916
5. Khan N, Javed Z, Acquah I, et al. Low educational attainment is associated with higher all-cause and cardiovascular mortality in the United States adult population. BMC Public Health. 2023;23(1):900. Published 2023 May 16. doi:10.1186/s12889-023-15621-y
6. Kim KW, Won YL, Ko KS, Heo KH, Chung YH. The effects of hazardous chemical exposure on cardiovascular disease in chemical products manufacturing workers. Toxicol Res. 2012 Dec;28(4):269-77. doi: 10.5487/TR.2012.28.4.269.
7. Kivimäki M, Kawachi I. Work Stress as a Risk Factor for Cardiovascular Disease. Curr Cardiol Rep. 2015;17(9):630. doi:10.1007/s11886-015-0630-8
8. Kondo T, Nakano Y, Adachi S, Murohara T. Effects of Tobacco Smoking on Cardiovascular Disease. Circ J. 2019;83(10):1980-1985. doi:10.1253/circj.CJ-19-0323
9. Koolhaas CM, Dhana K, Schoufour JD, Ikram MA, Kavousi M, Franco OH. Impact of physical activity on the association of overweight and obesity with cardiovascular disease: The Rotterdam Study. Eur J Prev Cardiol. 2017 Jun;24(9):934-941. doi: 10.1177/2047487317693952.
10. Makar A, Al-Hemoud A, Khraishah H, Berry J, Alahmad B. A Review of the Links Between Work and Heart Disease in the 21st Century. Methodist Debakey Cardiovasc J. 2024 Nov 5;20(5):71-80. doi: 10.14797/mdcvj.1478.
11. Mulle JG, Vaccarino V. Cardiovascular disease, psychosocial factors, and genetics: the case of depression. Prog Cardiovasc Dis. 2013 May-Jun;55(6):557-62. doi: 10.1016/j.pcad.2013.03.005.
12. Powell-Wiley TM, Poirier P, Burke LE, Després JP, Gordon-Larsen P, et al. American Heart Association Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Council on Epidemiology and Prevention; and Stroke Council. Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 2021 May 25;143(21):e984-e1010. doi: 10.1161/CIR.0000000000000973.
13. Prokopowicz A, Sobczak A, Szuła-Chraplewska M, Zaciera M, Kurek J, Szołtysek-Bołdys I. Effect of occupational exposure to lead on new risk factors for cardiovascular diseases. Occup Environ Med. 2017;74(5):366-373. doi:10.1136/oemed-2016-103996
14. Singh M, Nag A, Gupta L, Thomas J, Ravichandran R, Panjiyar BK. Impact of Social Support on Cardiovascular Risk Prediction Models: A Systematic Review. Cureus. 2023 Sep 24;15(9):e45836. doi: 10.7759/cureus.45836.
15. Vrablik M, Dlouha D, Todorovova V, Stefler D, Hubacek JA. Genetics of Cardiovascular Disease: How Far Are We from Personalized CVD Risk Prediction and Management? Int J Mol Sci. 2021 Apr 17;22(8):4182. doi: 10.3390/ijms22084182.
16. Wazir M, Olanrewaju OA, Yahya M, Kumari J, Kumar N, Singh J, et al. Lipid Disorders and Cardiovascular Risk: A Comprehensive Analysis of Current Perspectives. Cureus. 2023 Dec 31;15(12):e51395. doi: 10.7759/cureus.51395.
Review
For citations:
Muldasheva N.A., Zaydullin I.I., Karimov D.O., Karimova L.K., Shapoval I.V., Gimaeva Z.F. Assessment of the role of various factors in the development of arterial hypertension in workers of chemical enterprises by applying machine learning. Yakut Medical Journal. 2025;(2):75-79. https://doi.org/10.25789/YMJ.2025.90.16